2 December 2019

AMRA Medical Announces Abstract Accepted for Presentation at the 2019 International SCWD Conference in Berlin

AMRA Medical Announces Abstract Accepted for Presentation at the 2019 International SCWD Conference in Berlin

LINKÖPING, Sweden; December 2, 2019 – The SCWD – Society on Sarcopenia, Cachexia and Wasting Disorders – aims to progress research and bring practical solutions to health-care teams worldwide.

AMRA’s abstract describing the use of their innovative technology and method to detect individuals with adverse muscle composition has been accepted for poster presentation at the 12thInternational SCWD Conference in Berlin.  The abstract was also selected as one of three finalists for the Young Investigator Award, recognizing Jennifer Linge’s deep scientific contributions to further the sarcopenia field.  AMRA will present their research illustrating the importance of identifying adverse muscle composition within obesity using MRI data from the large UK Biobank Imaging Study.

A recent study showed that sarcopenia is underdiagnosed within obesity mainly due to current sarcopenia definitions being BMI-dependent and the correlation between body size and muscle mass insufficiently adjusted1. AMRA scientists quantified fat-free muscle volume and muscle fat infiltration in a study of 9 612 participants using a 6-minute MRI protocol, automated image analysis (AMRA® Researcher), and utilized sex and BMI-matched virtual control groups to create a personalized muscle volume z-score for each participant. They observed that participants with obesity commonly had adverse muscle composition, which was associated with a high prevalence of low functional performance and metabolic comorbidities.

Abstract Title: Adverse muscle composition within obesity is associated with low functional performance and increased comorbidity – Results from the large UK Biobank imaging study

Poster Presentation
Session: Poster Session 1.4
Location: Maritim proArte Hotel Berlin, Friedrichstraße 151
Date & Time: Friday, December 6, 2019 from 16:05-16:55 pm
Welcome Reception with Poster Viewing will be held in the poster area at 18:30-20:00 pm

Oral Presentation 
Session: Q – Young Investigators Awards Session
Location: Maritim proArte Hotel Berlin, Friedrichstraße 151
Date & Time: Sunday, December 8, 2019 from 08:30-10:00 am

References:
1. Linge J, Heymsfield SB, Dahlqvist Leinhard O. On the Definition of Sarcopenia in the Presence of Aging and Obesity – Initial Results from UK Biobank. The Journals of Gerontology: Series A 2019. doi: https://doi.org/10.1093/gerona/glz229.
Information about SCWD

AMRA is a ground-breaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, rapid, whole-body MRI. AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making from clinical research to health and wellness.

Contact

Marie Börjesson
Senior Director, Brand & Marketing
marie.borjesson@amramedical.com

comment

Latest News

language

Meet Us Here